By Associate Professor Charles Edo de Bock

Preprints

Germon ZP; Sillar JR; Mannan A; Duchatel RJ; Staudt D; Murray HC; Findlay IJ; Jackson ER; McEwen HP; Douglas AM; McLachlan T; Schjenken JE; Skerrett-Bryne DA; Huang H; Melo-Braga MN; Plank MW; Alvaro F; Chamberlain J; De Iuliis G; Aitken RJ; Nixon B; Wei AH; Enjeti AK; Lock RB; Larsen MR; Lee H; de Bock CE; Verrills NM; Dun MD, Blockade of redox second messengers inhibits JAK/STAT and MEK/ERK signaling sensitizing FLT3-mutant acute myeloid leukemia to targeted therapies, http://dx.doi.org/10.1101/2022.03.09.483687

Bond DR; Burnard SM; Uddipto K; Hunt KV; Harvey BM; Reinhardt LS; Lawlor-O’Neill C; Roper EA; Humphries S; Murray HC; Mannan A; Dun MD; de Bock CE; Bowden NA; Enjeti AK; Verrills NM; Riveros C; Cao K-AL; Lee HJ, Hypomethylating agents induce epigenetic and transcriptional heterogeneity with implications for AML cell self-renewal, http://dx.doi.org/10.1101/2024.01.30.577864

Jing D; Beck D; Cao H; Tian F; Huang Y; Zhao H; Tai X; XU W; Kosasih H; Kealy D; Bridge K; Zhao W; Holding A; Dowle A; Taylor S; Song G; Fajardo D; Walia Y; Wang M; Zhang C; Wang J; Mi J-Q; Lock R; de Bock C, PU.1 Eviction at Lymphocyte-Specific Chromatin Domains Mediates Glucocorticoid Response in Acute Lymphoblastic Leukemia, http://dx.doi.org/10.21203/rs.3.rs-3872306/v1

Zhang Q; Li MK; Hu XY; Wang YY; Zhao PP; Cheng LN; Yu RH; Zhang XD; Chen S; Zhu ZM; de Bock CE; Thorne RF, The tumour suppressor Fat1 is dispensable for normal murine hematopoiesis, http://dx.doi.org/10.1101/2023.12.20.572284

Back to profile page